Knapp W P, Soares B G O, Farrel M, Lima M S
Universidade Federal do Rio Grande do Sul, Psychiatry, Avenue Paulo Gama 110, Porto Alegre, Brazil.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD003023. doi: 10.1002/14651858.CD003023.pub2.
The consumption of psychostimulants for non-medical reasons probably occurs because of their euphoriant and psychomotor-stimulating properties. Chronic consumption of these agents results in development of stereotyped behaviour, paranoia, and possibly aggressive behaviour. Psychosocial treatments for psychostimulant use disorder are supposed to improve compliance, and to promote abstinence. Evidence from randomised controlled trials in this subject needs to be summarised.
To conduct a systematic review of all RCTs on psychosocial interventions for treating psychostimulant use disorder.
Electronic searches of Cochrane Library, EMBASE, MEDLINE, and LILACS (to may 2006); reference searching; personal communication; conference abstracts; unpublished trials from pharmaceutical industry; book chapters on treatment of psychostimulants abuse/ dependence.
All randomised-controlled trials focusing on psychosocial interventions for treating psychostimulants abuse/ dependence.
Three authors extracted the data independently and Relative Risks, weighted mean difference and number needed to treat were estimated, when possible. The reviewers assumed that people who died or dropped out had no improvement (intention to treat analysis) and tested the sensitivity of the final results to this assumption.
Twenty-seven randomised controlled studies (3663 participants) fulfilled inclusion criteria and had data that could be used for at least one of the main comparisons. There was a wide heterogeneity in the interventions evaluated: this did not allow to provide a summary estimate of effect and results cannot be summarised in a clear cut way. The comparisons between different type of Behavioural Interventions showed results in favour of treatments with some form of Contingency management in respect to both reducing drop outs and lowering cocaine use..
AUTHORS' CONCLUSIONS: Overall this review reports little significant behavioural changes with reductions in rates of drug consumption following an intervention. Moreover, with the evidence currently available, there are no data supporting a single treatment approach that is able to comprise the multidimensional facets of addiction patterns and to significantly yield better outcomes to resolve the chronic, relapsing nature of addiction, with all its correlates and consequences.
出于非医疗原因使用精神兴奋剂,可能是因其具有欣快感和精神运动刺激特性。长期使用这些药物会导致刻板行为、偏执,甚至可能引发攻击行为。针对精神兴奋剂使用障碍的社会心理治疗旨在提高依从性并促进戒断。需要总结该主题随机对照试验的证据。
对所有治疗精神兴奋剂使用障碍的社会心理干预随机对照试验进行系统评价。
电子检索Cochrane图书馆、EMBASE、MEDLINE和LILACS(至2006年5月);参考文献检索;个人交流;会议摘要;制药行业未发表的试验;关于精神兴奋剂滥用/依赖治疗的书籍章节。
所有聚焦于治疗精神兴奋剂滥用/依赖的社会心理干预的随机对照试验。
三位作者独立提取数据,并在可能的情况下估计相对风险、加权平均差和需治疗人数。 reviewers假设死亡或退出的人没有改善(意向性分析),并测试了最终结果对该假设的敏感性。
27项随机对照研究(3663名参与者)符合纳入标准,且有可用于至少一项主要比较的数据。所评估的干预措施存在广泛异质性:这使得无法提供效应的汇总估计,结果也无法以明确的方式进行总结。不同类型行为干预之间的比较表明,就减少退出率和降低可卡因使用而言,某种形式的应急管理治疗更具优势。
总体而言,本综述报告称干预后药物消费率降低,但行为变化不显著。此外,根据目前可得的证据,没有数据支持单一治疗方法能够涵盖成瘾模式的多方面维度,并显著产生更好的结果来解决成瘾的慢性复发性本质及其所有相关因素和后果。